Delivering a newborn with macrosomia (weighing more than 8 pounds, 13 ounces at birth) may be associated with higher risk of adverse outcomes, including perinatal death and injuries related to traumatic delivery, such as stuck shoulders (shoulder dystocia). A study in PLOS Medicine by Gordon Smith at the University of Cambridge and colleagues suggests that third trimester fetal ultrasound screening has the ability to identify more pregnancies with macrosomia.
The diagnostic effectiveness of ultrasound screening in predicting the delivery of a macrosomic infant, shoulder dystocia and associated neonatal morbidity is not well established. To better understand the relationship between estimated fetal weight (EFW), macrosomia, and perinatal complications, researchers systematically reviewed the literature from four different clinical databases. The authors then analyzed 41 studies involving 112,034 non-high risk patients who had undergone a third trimester ultrasound screening as part of universal screening.
The authors found that a third trimester ultrasonic EFW
Expanding routine newborn screening to include a metabolic vulnerability profile could lead to earlier detection of life-threatening complications in babies born preterm, according to a study by UC San Francisco researchers. The new method, which was developed at UCSF, offers valuable and time-sensitive insights into which infants are at greatest risk during their most vulnerable time, immediately after birth.
The study, published in Nature Pediatric Research by scientists at the UCSF California Preterm Birth Initiative (PTBI-CA), assessed the records of 9,639 preterm infants who experienced mortality or at least one complication or mortality.
Using the results of standard newborn profiles and blood tests, they identified a combination of six newborn characteristics and 19 metabolites that, together, created a vulnerability profile that reliably identified preterm babies at substantially increased risk for death and severe illness.
“Our results point to a number of potential biological pathways that may play a key role
AURORA, Colo. (KDVR) — The University of Colorado Anschutz Medical Campus in Aurora announced Tuesday the addition of new technology that researchers say could cut the screening time for new drug therapies in half.
Researchers say the new robotic screening and imaging technology could speed up the development of treatments for COVID, cancer or other diseases, while putting Colorado on the map in this field.
“Similar technologies exist on the coasts in academic institutions, but nothing in this region,” said Dr. David Ross, an associate dean at the CU Skaggs School of Pharmacy and Pharmaceutical Sciences.
He and his colleagues say the machine can take a library with thousands of compounds and quickly screen them against targets in a disease.
“If the disease model took two weeks to screen, we can now screen it in a couple of days,” said Dr. Dan LaBarbera, a researcher who will be using the
Nuvoola’s Luke AI Health Screening and Protection solution
Teledyne DALSA’s Calibir GXF thermal camera is a critical component within the Nuvoola Luke AI HSP solution
WATERLOO, Ontario, Oct. 06, 2020 (GLOBE NEWSWIRE) — Teledyne DALSA, a Teledyne Technologies [NYSE:TDY] company, and global leader in digital imaging technology, is pleased to provide its new Calibir GXF thermal camera as a critical component within Nuvoola’s LUKE™ AI Health Screening and Protection (HSP) solution.
The new Calibir GXF model is optimized for elevated skin temperature detection with measurement accuracy and thermal stability better than +/-0.3°C with an external reference (as recommended by IEC80601-2-59). Like Calibir GXM models, the new GXF camera is NDAA, Section 889 compliant with IEC 80601-2-59-2017 certification pending.
Nuvoola’s LUKE™ AI Health Screening and Protection (HSP) solution is unique in using their artificial
COLONIE — New scanners intended to verify the validity of a passenger’s identification have been introduced at Albany International Airport security checkpoints, according to the Transportation Security Administration.
The scanners can also confirm the traveler’s flight information in near real time, the TSA said Monday.
Tests for skin treatments could be screened using flatworms rather than other animals such as rabbits, according to new research.
A team at the University of Reading and Newcastle University have found that planaria, a type of flatworm, can be used as a reliable alternative for testing topical skin products used to treat human tissues such as the eyes, nose or vagina to ensure that they are not harmful.
The paper, published in Toxicology in Vitro, shows how the use of a fluorescent dye mixed with a potential skin product is absorbed through the outer layers of skin in the planaria.
The tests are cheaper and more ethical than existing animal tests, because planaria are readily available and easily cultured in a laboratory — and don’t experience suffering. While other tests are carried out on human skin cells in a petri dish, the new screening method would provide a
An app that uses a smartphone camera to process wavelength measurements of blood vessels directly under the skin through artificial intelligence can more easily determine if an individual is at risk of being infected and requires medical assistance.
Since the advent of the smartphone, it seems whenever something important needs to be done, someone, somewhere will say: “If only there were an app for that.” In today’s world, where we face both the fear of COVID-19 infection and that of the need to successfully reopen the economy, an app that can easily determine whether a person is infected or not could be a game-changer in the fight against the virus.
It is clear that in order to reopen the economy, businesses need to be able to ensure they can operate without posing a risk to either their employees, their customers or the general public.
Tel Aviv University researchers suggest that carriers of the genetic mutations PiZ and PiS are at high risk for severe illness and even death from COVID-19. These mutations lead to deficiency in the alpha1-antitrypsin protein, which protects lung tissues from damage in case of severe infections. Other studies have already associated deficiency in this protein with inflammatory damage to lung function in other diseases.
The study was led by Prof. David Gurwitz, Prof. Noam Shomron, and MSc candidate Guy Shapira of TAU’s Sackler Faculty of Medicine, and published in The FASEB Journal on September 22, 2020.
The researchers analyzed data from 67 countries on all continents. Comparisons revealed a highly significant positive correlation between the prevalence of the two mutations in the population and COVID-19 mortality rates (adjusted to size of the population) in many countries, such as the USA, the UK, Belgium, Spain, Italy, and more.
Top 5 Considerations When Implementing Temperature Screening Technology
Human Temperature Screening solutions will be critical in outlining a new normal to keep people safe and reduce business risk and liabilities.
By Rich Mellot
Sep 18, 2020
The COVID-19 pandemic has posed ongoing challenges for various industries, but it has also kindled an incredible amount of innovation. Existing security technologies have been modified to help mitigate the exposure of symptomatic individuals in the workplace, while others have been developed to help organizations rethink workplace safety and security altogether. Demand for one such technology has exploded in recent months, quickly becoming one of the most talked-about security solutions: human temperature screening (HTS).
While these devices are becoming increasingly critical in helping organizations create safer, healthier environments, they come with various compliance considerations and regulatory requirements that leave many businesses wondering where human temperature screening fits into their overall